A substrate-driven allosteric switch that enhances PDI catalytic activity.

Nat Commun

Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.

Published: August 2016

Protein disulfide isomerase (PDI) is an oxidoreductase essential for folding proteins in the endoplasmic reticulum. The domain structure of PDI is a-b-b'-x-a', wherein the thioredoxin-like a and a' domains mediate disulfide bond shuffling and b and b' domains are substrate binding. The b' and a' domains are connected via the x-linker, a 19-amino-acid flexible peptide. Here we identify a class of compounds, termed bepristats, that target the substrate-binding pocket of b'. Bepristats reversibly block substrate binding and inhibit platelet aggregation and thrombus formation in vivo. Ligation of the substrate-binding pocket by bepristats paradoxically enhances catalytic activity of a and a' by displacing the x-linker, which acts as an allosteric switch to augment reductase activity in the catalytic domains. This substrate-driven allosteric switch is also activated by peptides and proteins and is present in other thiol isomerases. Our results demonstrate a mechanism whereby binding of a substrate to thiol isomerases enhances catalytic activity of remote domains.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013553PMC
http://dx.doi.org/10.1038/ncomms12579DOI Listing

Publication Analysis

Top Keywords

allosteric switch
12
catalytic activity
12
substrate-driven allosteric
8
substrate binding
8
substrate-binding pocket
8
pocket bepristats
8
enhances catalytic
8
thiol isomerases
8
domains
5
switch enhances
4

Similar Publications

Persisters describe phenotypically switched cells refractory to antibiotic killing in a genetically susceptible population, while preserving the ability to resume growth when antibiotics are discontinued1,2. Since its proposal 70 years ago, great strides were made to build the framework regarding persistence, including defining triggered, spontaneous and antibiotic-induced persisters. However, challenges remain in characterizing the molecular determinants underlying the phenotypic switch into persistence3.

View Article and Find Full Text PDF

BRM (SMARCA2) and BRG1 (SMARCA4) are mutually exclusive ATPase subunits of the mSWI/SNF (BAF) chromatin remodeling complex. BAF is an attractive therapeutic target because of its role in transcription, and mutations in the subunits of BAF are common in cancer and neurological disorders. Herein, we report the discovery of compound () as a potent allosteric inhibitor of the dual ATPase subunits from a high-throughput screening hit with a BRM IC of ∼27 μM.

View Article and Find Full Text PDF

The src-homology 2 domain-containing phosphatase 2 (SHP2) is a human cytoplasmic protein tyrosine phosphatase that plays a crucial role in cellular signal transduction. Aberrant activation and mutations of SHP2 are associated with tumor growth and immune suppression, thus making it a potential target for cancer therapy. Initially, researchers sought to develop inhibitors targeting SHP2's catalytic site (protein tyrosine phosphatase domain, PTP).

View Article and Find Full Text PDF
Article Synopsis
  • RbgA is a GTPase that plays a crucial role in the maturation of the 50S ribosomal subunit, favoring its GTP-bound state over the GDP-bound state due to conformational differences.
  • All-atom molecular dynamics simulations revealed significant conformational changes in RbgA depending on the bound nucleotide, particularly under GTP-Mg and GMPPNP-Mg conditions, which may impact its function.
  • The study identifies key regions that influence RbgA's ribosome association and suggests that understanding these mechanisms can help develop new chemical agents to regulate ribosome biogenesis.
View Article and Find Full Text PDF

A Modular Engineered DNA Nanodevice for Precise Profiling of Telomerase RNA Location and Activity.

Adv Sci (Weinh)

December 2024

State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.

Increased telomerase activity has been considered as a conspicuous sign of human cancers. The catalytic cores of telomerase involve a reverse transcriptase and the human telomerase RNA (hTR). However, current detection of telomerase is largely limited to its activity at the tissue and single-cell levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!